These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 20634941)
1. In vitro inhibition of neutrophil elastase activity by inhaled anti-Pseudomonas antibiotics used in cystic fibrosis patients. Hector A; Kappler M; Griese M Mediators Inflamm; 2010; 2010():809591. PubMed ID: 20634941 [TBL] [Abstract][Full Text] [Related]
2. Colistin stimulates the activity of neutrophil elastase and Pseudomonas aeruginosa elastase. Jones A; Elphick H; Pettitt E; Everard ML; Evans GS Eur Respir J; 2002 Jun; 19(6):1136-41. PubMed ID: 12108869 [TBL] [Abstract][Full Text] [Related]
3. Colistin-tobramycin combinations are superior to monotherapy concerning the killing of biofilm Pseudomonas aeruginosa. Herrmann G; Yang L; Wu H; Song Z; Wang H; Høiby N; Ulrich M; Molin S; Riethmüller J; Döring G J Infect Dis; 2010 Nov; 202(10):1585-92. PubMed ID: 20942647 [TBL] [Abstract][Full Text] [Related]
4. The Effects of Antibiotic Combination Treatments on Pseudomonas aeruginosa Tolerance Evolution and Coexistence with Stenotrophomonas maltophilia. Law JP; Wood AJ; Friman VP Microbiol Spectr; 2022 Dec; 10(6):e0184222. PubMed ID: 36453898 [TBL] [Abstract][Full Text] [Related]
5. Chronic inhaled antibiotic therapy in people with cystic fibrosis with Pseudomonas aeruginosa infection in Germany. Naehrig S; Schulte-Hubbert B; Hafkemeyer S; Hammermann J; Dumke M; Sieber S; ; Naehrlich L Pulm Pharmacol Ther; 2023 Jun; 80():102214. PubMed ID: 37003541 [TBL] [Abstract][Full Text] [Related]
6. In vitro activity of the aerosolized agents colistin and tobramycin and five intravenous agents against Pseudomonas aeruginosa isolated from cystic fibrosis patients in southwestern Germany. Schülin T J Antimicrob Chemother; 2002 Feb; 49(2):403-6. PubMed ID: 11815589 [TBL] [Abstract][Full Text] [Related]
7. Outpatient treatment of Pseudomonas aeruginosa bronchial colonization with long-term inhaled colistin, tobramycin, or both in adults without cystic fibrosis. Berlana D; Llop JM; Manresa F; Jódar R Pharmacotherapy; 2011 Feb; 31(2):146-57. PubMed ID: 21275493 [TBL] [Abstract][Full Text] [Related]
8. Inhaled tobramycin (TOBI): a review of its use in the management of Pseudomonas aeruginosa infections in patients with cystic fibrosis. Cheer SM; Waugh J; Noble S Drugs; 2003; 63(22):2501-20. PubMed ID: 14609360 [TBL] [Abstract][Full Text] [Related]
9. Resistance to tobramycin and colistin in isolates of Pseudomonas aeruginosa from chronically colonized patients with cystic fibrosis under antimicrobial treatment. Valenza G; Radike K; Schoen C; Horn S; Oesterlein A; Frosch M; Abele-Horn M; Hebestreit H Scand J Infect Dis; 2010 Dec; 42(11-12):885-9. PubMed ID: 20735333 [TBL] [Abstract][Full Text] [Related]
10. [Inhalational antibiotic therapy in patients with cystic fibrosis and Pseudomonas infection]. Mordasini C; Aebischer CC; Schoch OD Schweiz Med Wochenschr; 1997 May; 127(21):905-10. PubMed ID: 9289818 [TBL] [Abstract][Full Text] [Related]
11. [Use of inhaled tobramycin in patients with cystic fibrosis]. Chermenskiĭ AG; Gembitskaia TE Ter Arkh; 2010; 82(8):76-8. PubMed ID: 20873251 [TBL] [Abstract][Full Text] [Related]
12. [Nebulized colistin versus tobramycin in the treatment of chronic Pseudomonas colonization in cystic fibrosis patients]. Quintana-Gallego E; Lopez-Campos JL; Calero C; Dapena FJ Med Clin (Barc); 2014 Jan; 142(2):59-63. PubMed ID: 23369499 [TBL] [Abstract][Full Text] [Related]
13. Sequential Inhalational Tobramycin-Colistin-Combination in CF-Patients with Chronic P. Aeruginosa Colonization - an Observational Study. Riethmüller J; Herrmann G; Graepler-Mainka U; Hellwig D; Heuer HE; Heyder S; Köster H; Kinder B; Kröger K; Paul K; Poplawska K; Melichar VO; Smaczny C; Mellies U Cell Physiol Biochem; 2016; 39(3):1141-51. PubMed ID: 27576543 [TBL] [Abstract][Full Text] [Related]
14. Tobramycin and Colistin display anti-inflammatory properties in CuFi-1 cystic fibrosis cell line. Sheikh Z; Bradbury P; Reekie TA; Pozzoli M; Robinson PD; Kassiou M; Young PM; Ong HX; Traini D Eur J Pharmacol; 2021 Jul; 902():174098. PubMed ID: 33848541 [TBL] [Abstract][Full Text] [Related]
15. Inhaled antibiotics for the treatment of chronic bronchopulmonary Pseudomonas aeruginosa infection in cystic fibrosis: systematic review of randomised controlled trials. Máiz L; Girón RM; Olveira C; Quintana E; Lamas A; Pastor D; Cantón R; Mensa J Expert Opin Pharmacother; 2013 Jun; 14(9):1135-49. PubMed ID: 23586963 [TBL] [Abstract][Full Text] [Related]
16. Insights into cystic fibrosis microbiology from the European tobramycin trial in cystic fibrosis. Govan JR J Cyst Fibros; 2002 Dec; 1(Suppl 2):203-8. PubMed ID: 15463836 [TBL] [Abstract][Full Text] [Related]
17. Open follow-up study of tobramycin nebuliser solution and colistin in patients with cystic fibrosis. Adeboyeku D; Scott S; Hodson ME J Cyst Fibros; 2006 Dec; 5(4):261-3. PubMed ID: 16807142 [TBL] [Abstract][Full Text] [Related]
18. Novel inhaled combined antibiotic formulations in the treatment of Pseudomonas aeruginosa airways infections in cystic fibrosis. Antoniu S Expert Rev Anti Infect Ther; 2015 Jul; 13(7):897-905. PubMed ID: 25921312 [TBL] [Abstract][Full Text] [Related]
19. A randomised clinical trial of nebulised tobramycin or colistin in cystic fibrosis. Hodson ME; Gallagher CG; Govan JR Eur Respir J; 2002 Sep; 20(3):658-64. PubMed ID: 12358344 [TBL] [Abstract][Full Text] [Related]